A drug company in Columbia has agreed to stop manufacturing prescription cough and prescription cold products due to repeatedly failing to have federal approval or pass inspections.

The Chief Executive Officer of Scientific Laboratories Inc., Amit Roy, along with President Rajeshwari Patel, signed a consent decree. The signing process took place earlier this month in a U.S. District Court in Baltimore.

The U.S. Food and Drug Administration (FDA) has sought to sanction the company because they have never received approval for their products. Scientific Laboratories Inc. has been making prescription drug products for other pharmaceutical companies. After the drugs were made, other companies could sell them under their own labels.

Under the consent decree that was signed, Scientific Laboratories is required to recall all products that it has sold since January 1, 2007. The company will require FDA approval before they will be allowed to manufacture any form of medication – prescription or over-the-counter.

Defective drug attorneys are working on cases in which people have suffered from serious illness as a result of negligence.

This entry was posted on Tuesday, May 20th, 2008 at 9:35 pm and is filed under Defective Drugs, Medication, Recall, Safety. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.